What is Haemonetics Corporation's Market Cap?

Haemonetics Corporation's Market Cap is $4.7B, based on as-reported figures from SEC (XBRL) filings.

What is Haemonetics Corporation's Enterprise Value?

Haemonetics Corporation's Enterprise Value is $5.6B, based on as-reported figures from SEC (XBRL) filings.

What is Haemonetics Corporation's Trailing P/E?

Haemonetics Corporation's Trailing P/E is 48.7×, based on as-reported figures from SEC (XBRL) filings.

What is Haemonetics Corporation's Price / Sales?

Haemonetics Corporation's Price / Sales is 3.5×, based on as-reported figures from SEC (XBRL) filings.

What is Haemonetics Corporation's EV / Revenue?

Haemonetics Corporation's EV / Revenue is 4.2×, based on as-reported figures from SEC (XBRL) filings.

What is Haemonetics Corporation's EV / EBITDA?

Haemonetics Corporation's EV / EBITDA is 20.8×, based on as-reported figures from SEC (XBRL) filings.

What is Haemonetics Corporation's Revenue (TTM)?

Haemonetics Corporation's Revenue (TTM) is $1.4B, based on as-reported figures from SEC (XBRL) filings.

What is Haemonetics Corporation's Net Income (TTM)?

Haemonetics Corporation's Net Income (TTM) is $96.3M, based on as-reported figures from SEC (XBRL) filings.

What is Haemonetics Corporation's EBITDA?

Haemonetics Corporation's EBITDA is $270.4M, based on as-reported figures from SEC (XBRL) filings.

What is Haemonetics Corporation's Diluted EPS (TTM)?

Haemonetics Corporation's Diluted EPS (TTM) is 2.12, based on as-reported figures from SEC (XBRL) filings.

Haemonetics Corporation (HAE) Financial Statements

Haemonetics Corporation

SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

FIGI BBG001S6QB64

XNYS · usd

103.16▲ 0.32 (0.31%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close102.84

Day's Range100.57 – 103.18

52-Week Range47.32 – 109.57

Volume612.2K

Avg Volume789.1K

Share Statistics

Shares Outstanding

Employees3,023

ExchangeXNYS

Listed1991-05-09

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Haemonetics Corporation (HAE)

What is Haemonetics Corporation's Market Cap?: Haemonetics Corporation's Market Cap is $4.7B, based on as-reported figures from SEC (XBRL) filings.
What is Haemonetics Corporation's Enterprise Value?: Haemonetics Corporation's Enterprise Value is $5.6B, based on as-reported figures from SEC (XBRL) filings.
What is Haemonetics Corporation's Trailing P/E?: Haemonetics Corporation's Trailing P/E is 48.7×, based on as-reported figures from SEC (XBRL) filings.
What is Haemonetics Corporation's Price / Sales?: Haemonetics Corporation's Price / Sales is 3.5×, based on as-reported figures from SEC (XBRL) filings.
What is Haemonetics Corporation's EV / Revenue?: Haemonetics Corporation's EV / Revenue is 4.2×, based on as-reported figures from SEC (XBRL) filings.
What is Haemonetics Corporation's EV / EBITDA?: Haemonetics Corporation's EV / EBITDA is 20.8×, based on as-reported figures from SEC (XBRL) filings.
What is Haemonetics Corporation's Revenue (TTM)?: Haemonetics Corporation's Revenue (TTM) is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is Haemonetics Corporation's Net Income (TTM)?: Haemonetics Corporation's Net Income (TTM) is $96.3M, based on as-reported figures from SEC (XBRL) filings.
What is Haemonetics Corporation's EBITDA?: Haemonetics Corporation's EBITDA is $270.4M, based on as-reported figures from SEC (XBRL) filings.
What is Haemonetics Corporation's Diluted EPS (TTM)?: Haemonetics Corporation's Diluted EPS (TTM) is 2.12, based on as-reported figures from SEC (XBRL) filings.